Molecular approaches to diagnosing and managing infectious diseases: Practicality and costs

Emerging Infectious Diseases

Volumn 7, Issue 2, 2001, Pages 312-318

  Pfaller, Michael A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM DETECTION; CONFERENCE PAPER; COST UTILITY ANALYSIS; DIAGNOSTIC APPROACH ROUTE; GENE AMPLIFICATION; INFECTION; LABORATORY; NONHUMAN; PATIENT CARE; POLYMERASE CHAIN REACTION;

EID: 0035029386     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0702.010234     Document Type: Conference Paper

References (23)

1. Molecular pathology of infectious diseases
2. Diagnosis and management of infectious diseases: Molecular methods for the new millennium
3. Molecular diagnostics: Reimbursement and other selected financial issues
4. Sequence-based identification of microbial pathogens: A reconsideration of Koch's postulates
5. Application of polymerase chain reaction to the diagnosis of infectious disease
6. Molecular detection and identification of microorganisms
7. Molecular techniques in mycobacterial detection
8. Preventing antibiotic resistance using rapid DNA-based diagnostic tests
9. Genetic methods for assessing antimicrobial resistance
10. Medical and economic benefit of a comprehensive infection control program that includes routine determination of microbial clonality
11. Financial determinants of outcomes in molecular testing
12. Molecular epidemiology in the care of patients
13. Impact of viral load testing on patient care
14. Rapid diagnosis of bacteremia by universal amplification of 23S ribosomal DNA followed by hybridization to an oligonucleotide array
15. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: Frequency of occurrence, antimicrobial susceptibility, and molecular (mec A) characterization of oxacillin resistance in the SCOPE Program
16. Correlation of oxacillin MIC with mec A gene carriage in coagulase-negative staphylococci
17. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors
18. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy
19. Genotypic approach to the study of bacterial resistance to antibiotics
20. Laboratory procedures for epidemiologic analysis of microorganisms
21. The clinical microbiology laboratory and infection control: Emerging pathogens, antimicrobial resistance, and new technology
22. Pitfalls in establishing a molecular diagnostic laboratory
23. Recurrent epidemics caused by a single strain of erythromycin-resistant Staphylococcus aureus: The importance of molecular epidemiology